UNSPSC 51286200: Antibacterial organophosphorus compounds

This classification denotes antibacterial compounds that bear as an integral part of their molecule phosphorous.

UNSPSC 51286200 Antibacterial organophosphorus compounds, a Class code, shows persistent mismatch between its nominal scope and actual state and local procurement activity. Recent opportunities posted under this code do not involve antibacterial organophosphorus compounds; instead, issuing bodies are buying naloxone (opioid reversal agents), medical and first aid supplies for emergency response, generic pharmaceuticals and OTC products through cooperative purchasing, and exploring direct-to-manufacturer pharmacy programs. Naloxone and drug deactivation systems, medical consumables for fire rescue operations, and generic multi-source pharmaceutical products represent the concrete work being solicited under the code currently. Issuing bodies include county health departments, municipal fire services, state health and human services agencies, and multistate cooperative purchasing alliances. The code attracts solicitations from Florida counties, Texas state agencies, and Midwestern municipal and state purchasing offices participating in cooperative arrangements.

Seminole County, Florida posted an IFB (IFB60459723LAS, due July 26, 2023) seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries; the City of Tampa posted an IFB (26P00145, due March 13, 2026) for 169 line items of medical and first aid supplies—including respiratory equipment, cardiac monitoring electrodes, and consumables—estimated at $700,000 with a 5% bid discount reserved for certified Small Local Business Enterprises; and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued an RFP (S1070000015802, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products to be distributed across state and local government facilities in Minnesota and Oregon. The Texas Health and Human Services Commission posted an RFI (HHS0017013, April 3, 2026) exploring vendor capabilities for direct-to-manufacturer prescription programs. The code shows activity concentrated in state health and human services procurement, county health initiatives, and municipal emergency response supply chains, with cooperative purchasing vehicles playing a significant role in pharmaceutical distribution.